Literature DB >> 11264364

Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.

J L Greenier1, C J Miller, D Lu, P J Dailey, F X Lü, K J Kunstman, S M Wolinsky, M L Marthas.   

Abstract

A better understanding of the host and viral factors associated with human immunodeficiency virus (HIV) transmission is essential to developing effective strategies to curb the global HIV epidemic. Here we used the rhesus macaque-simian immunodeficiency virus (SIV) animal model of HIV infection to study the range of viral genotypes that are transmitted by different routes of inoculation and by different types of viral inocula. Analysis of transmitted variants was undertaken in outbred rhesus macaques inoculated intravenously (IV) or intravaginally (IVAG) with a genetically heterogeneous SIVmac251 stock derived from a well-characterized rhesus macaque viral isolate. In addition, we performed serial IV and IVAG passage experiments using plasma from SIV-infected macaques as the inoculum. We analyzed the V1-V2 region of the SIV envelope gene from virion-associated RNA in plasma from infected animals by the heteroduplex mobility assay (HMA) and by DNA sequence analysis. We found that a more diverse population of SIV genetic variants was present in the earliest virus-positive plasma samples from all five IV SIVmac251-inoculated monkeys and from two of five IVAG SIVmac251-inoculated monkeys. In contrast, we found a relatively homogeneous population of SIV envelope variants in three of five monkeys inoculated IVAG with SIVmac251 stock and in two monkeys infected after IVAG inoculation with plasma from an SIV-infected animal. In some IVAG-inoculated animals, the transmitted SIV variant was the most common variant in the inoculum. However, a specific viral variant in the SIVmac251 stock was not consistently transmitted by IVAG inoculation. Thus, it is likely that host factors or stochastic processes determine the specific viral variants that infect an animal after IVAG SIV exposure. In addition, our results clearly demonstrate that the route of inoculation is associated with the extent and breadth of the genetic complexity of the viral variant population in the earliest stages of systemic infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264364      PMCID: PMC114866          DOI: 10.1128/JVI.75.8.3753-3765.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Position and degree of mismatches and the mobility of DNA heteroduplexes.

Authors:  D A Upchurch; R Shankarappa; J I Mullins
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

2.  HIV-1 genomic RNA diversification following sexual and parenteral virus transmission.

Authors:  T F Wolfs; G Zwart; M Bakker; J Goudsmit
Journal:  Virology       Date:  1992-07       Impact factor: 3.616

3.  Rapid generation of sequence variation during primary HIV-1 infection.

Authors:  S Pang; Y Shlesinger; E S Daar; T Moudgil; D D Ho; I S Chen
Journal:  AIDS       Date:  1992-05       Impact factor: 4.177

4.  Gender differences in HIV-1 diversity at time of infection.

Authors:  E M Long; H L Martin; J K Kreiss; S M Rainwater; L Lavreys; D J Jackson; J Rakwar; K Mandaliya; J Overbaugh
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

5.  Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques.

Authors:  P A Luciw; C P Mandell; S Himathongkham; J Li; T A Low; K A Schmidt; K E Shaw; C Cheng-Mayer
Journal:  Virology       Date:  1999-10-10       Impact factor: 3.616

6.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

7.  Rates of spontaneous mutation among RNA viruses.

Authors:  J W Drake
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells.

Authors:  J Hu; M B Gardner; C J Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 9.  The evolution of RNA viruses: A population genetics view.

Authors:  A Moya; S F Elena; A Bracho; R Miralles; E Barrio
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

10.  Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus.

Authors:  C J Miller; N J Alexander; S Sutjipto; A A Lackner; A Gettie; A G Hendrickx; L J Lowenstine; M Jennings; P A Marx
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

View more
  42 in total

1.  Efficient transmission and persistence of low-frequency SIVmac251 variants in CD8-depleted rhesus macaques with different neuropathology.

Authors:  Samantha L Strickland; Rebecca R Gray; Susanna L Lamers; Tricia H Burdo; Ellen Huenink; David J Nolan; Brian Nowlin; Xavier Alvarez; Cecily C Midkiff; Maureen M Goodenow; Kenneth Williams; Marco Salemi
Journal:  J Gen Virol       Date:  2012-02-01       Impact factor: 3.891

2.  Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: implications for HIV-1 transmission in humans.

Authors:  Lily Tsai; Nataliya Trunova; Agegnehu Gettie; Hiroshi Mohri; Rudolf Bohm; Mohammed Saifuddin; Cecilia Cheng-Mayer
Journal:  Virology       Date:  2007-01-29       Impact factor: 3.616

3.  Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN.

Authors:  Li Wu; Arman A Bashirova; Thomas D Martin; Loreley Villamide; Erin Mehlhop; Andrei O Chertov; Derya Unutmaz; Melissa Pope; Mary Carrington; Vineet N KewalRamani
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

4.  Differential selection of specific human immunodeficiency virus type 1/JC499 variants after mucosal and parenteral inoculation of chimpanzees.

Authors:  Qing Wei; Patricia N Fultz
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques.

Authors:  Marta L Marthas; Koen K A Van Rompay; Zachary Abbott; Patricia Earl; Linda Buonocore-Buzzelli; Bernard Moss; Nina F Rose; John K Rose; Pamela A Kozlowski; Kristina Abel
Journal:  Vaccine       Date:  2011-03-04       Impact factor: 3.641

6.  Antigenic stimulation specifically reactivates the replication of archived simian immunodeficiency virus genomes in chronically infected macaques.

Authors:  Céline Renoux; Simon Wain-Hobson; Bruno Hurtrel; Rémi Cheynier
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3.

Authors:  Pushpa Jayaraman; Tuofu Zhu; Lynda Misher; Deepika Mohan; LaRene Kuller; Patricia Polacino; Barbra A Richardson; Helle Bielefeldt-Ohmann; David Anderson; Shiu-Lok Hu; Nancy L Haigwood
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques.

Authors:  Alexandra Mumbauer; Agegenhu Gettie; James Blanchard; Cecilia Cheng-Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

9.  Nonpathogenic CCR2-tropic SIVrcm after serial passage and its effect on SIVmac infection of Indian rhesus macaques.

Authors:  Binhua Ling; Ronald S Veazey; Preston A Marx
Journal:  Virology       Date:  2008-07-26       Impact factor: 3.616

10.  Differential pathogenicity of SHIV infection in pig-tailed and rhesus macaques.

Authors:  Patricia Polacino; Kay Larsen; Lindsey Galmin; John Suschak; Zane Kraft; Leonidas Stamatatos; David Anderson; Susan W Barnett; Ranajit Pal; Kristen Bost; A H Bandivdekar; Christopher J Miller; Shiu-Lok Hu
Journal:  J Med Primatol       Date:  2008-12       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.